Navigation Links
Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
Date:2/5/2009

Study Evaluating Cysteamine in Collaboration with UC San Diego

NOVATO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the completion of patient enrollment in its Phase 2a open-label clinical trial to evaluate cysteamine bitartrate ("cysteamine") in patients diagnosed with non-alcoholic steatohepatitis ("NASH"). NASH, a progressive form of liver disease that accounts for approximately 10% of newly diagnosed cases of chronic liver disease, is one of the leading causes of cirrhosis in the U.S. NASH patients are currently limited to managing their disease through weight control, diet and exercise.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

NASH is believed to affect 2% to 5% of the U.S. population. While commonly diagnosed in insulin-resistant obese adults, NASH can also occur in children, elderly and non-diabetic persons of average weight. Though most people with NASH feel healthy and show no outward signs of liver disease, NASH causes decreased liver function and potentially leads to cirrhosis, liver failure and end-stage liver disease. In more severe cases, the progressive nature of NASH may require liver transplantation in affected patients.

Under a collaboration agreement between the University of California, San Diego ("UC San Diego") and Raptor, UC San Diego is conducting the Phase 2a clinical trial at UC San Diego's General Clinical Research Center. In the six-month, open-label clinical trial, UC San Diego enrolled a total of 12 adolescent NASH patients receiving a twice daily oral dose of cysteamine and will measure possible reduction of blood alanine aminotransferase ("ALT") and aspartate aminotransferase ("AST") levels as a biomarker of cysteamine's efficacy for potentially t
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
2. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
3. Raptor Pharmaceuticals Provides Update on Targeting Platforms
4. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
5. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
6. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
7. Raptor Pharmaceuticals Provides Update of Product Programs
8. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
9. Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
10. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
11. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014 The Pennsylvania State Police will ... 27, as part of National Prescription Drug Take-Back Day. ... Take-Back Day is a national initiative, conducted ... aimed at encouraging the public to dispose of expired, ... abuse and theft. From 10 a.m. to ...
(Date:9/23/2014)... 23, 2014 Rising health ... and increasing number of foreign and domestic players in ... India   The ... most high growth potential markets worldwide due to multiple ... among the youth, changing food consumption patterns, increasing diabetic ...
(Date:9/23/2014)... Iowa , Sept. 23, 2014  KemPharm, ... the discovery and development of proprietary new molecular ... a No Objection Letter (NOL) from Health Canada ... for its lead product candidate KP201 ... prodrug in development for acute moderate to moderately ...
Breaking Medicine Technology:India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 3
... Calif., Aug. 2, 2011 Avanir Pharmaceuticals, Inc. ... will present an overview of the company at the following investor ... Conference Location: Intercontinental Hotel, Boston, MA Presentation ... Wedbush Life Sciences ...
... Mich., Aug. 2, 2011 Perrigo Company (Nasdaq: PRGO;TASE) today ... quarter fiscal 2011 on Tuesday, August 16 , 2011 at ... call at 10:00 a.m. (ET) hosted by Joseph C. Papa, ... call will be available live via webcast to interested parties ...
Cached Medicine Technology:
(Date:9/23/2014)... Oaksterdam University has begun publishing a blog called ... the University addresses the need for quality training in ... cannabis industry is becoming big business. According to ... of more than $600 million in revenues and taxes ... new legal recreational marijuana market in Washington State is ...
(Date:9/23/2014)... PREVENTION WORKSHOP: ROLE OF OPIOIDS IN THE TREATMENT OF ... Institutes of Health is convening a Pathways to Prevention ... long-term effectiveness and potential risks of opioids for treating ... experts in the field of pain control and management ... scientists who focus on pain related research. An impartial, ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 As a ... before making a purchase. It’s difficult to trust testimonials ... easy for them to manipulate their customers into saying ... dilemma, but they tend to lack in depth coverage ... Reports was founded to fix this issue and ...
(Date:9/23/2014)... Sept. 23, 2014 (HealthDay News) -- Both drinking and ... factors for alcohol abuse by high school students, a ... survey of high school students who drink, could help ... who already drink, to stop them from becoming binge ... between age of first alcohol use and progression to ...
(Date:9/23/2014)... York, NY (PRWEB) September 23, 2014 ... congregation on Manhattan’s Upper West Side that embodies ... host Inhabiting Eden: Christians, Scripture and the Ecological ... Tull, A. B. Rhodes Professor Emerita of Old ... the Bible for ancient wisdom that lends insight ...
Breaking Medicine News(10 mins):Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2
... in the spread of lung cancer as well as a likely ... study was published today (Monday, March 14) in the Journal ... The University of Texas MD Anderson Cancer Center found a way ... that shifts primary tumor cells into a more deadly type of ...
... Harbor, N.Y In a research study appearing in the ... Cold Spring Harbor Laboratory (CSHL) and four other institutions have ... which currently has limited treatment options and one of the ... experiments reveal that up to 15% of liver tumors are ...
... March 14, 2011The first human studies of an oral drug ... promising near 50% reduction in HIV incidence, but a number ... can be implemented on a large scale, according to an ... peer-reviewed journal published by Mary Ann Liebert, Inc. ( www.liebertpub.com ...
... Reporter , MONDAY, March 14 (HealthDay News) -- An ... earthquake-ravaged Japan,s Fukushima Dai-ichi nuclear complex, but officials insisted ... to news reports. Authorities had been scrambling ... earthquake and tsunami knocked out water systems and backup ...
... major study of the wellbeing and inclusion of former ... by Queen,s University today (Monday 14 March). ... in Northern Ireland and the border region of Ireland ... of loyalist and republican former prisoners (aged 50 and ...
... Researchers at Georgia Health Sciences University are studying ... protective metabolite could halt the progression of diabetic nephropathy, ... four year, $308,000 grant from the American Heart Association, ... the College of Dental Medicine and Pharmacology and Toxicology ...
Cached Medicine News:Health News:Study puts notch on the jagged edge of lung cancer metastasis 2Health News:Study puts notch on the jagged edge of lung cancer metastasis 3Health News:Study identifies therapeutic target for liver cancer and predictive biomarker of response 2Health News:Study identifies therapeutic target for liver cancer and predictive biomarker of response 3Health News:Early success of anti-HIV preventive oral drug regimen is promising, but questions remain 2Health News:Explosion Rocks 2nd Nuclear Reactor in Japan 2Health News:Explosion Rocks 2nd Nuclear Reactor in Japan 3Health News:Explosion Rocks 2nd Nuclear Reactor in Japan 4Health News:Report into well-being and inclusion of former politically motivated prisoners 2Health News:Report into well-being and inclusion of former politically motivated prisoners 3
... Celluthin effectively delivers clinically proven aminophylline directly ... reduction. Topical fat reduction with the aminophylline ... fat and an increase in the firmness ... deep into the skin where it causes ...
... Contour is a non-invasive massage machine ... and the circulatory system. Extraordinary results ... Directional-Stroking action, which combines vertical and ... comfortable percussion, gyratory massage, deep tissue ...
A device combining the "palpate & roll technique to vacuum massage, innovation dedicated to efficiency....
The Ritter 204 Manual Exam Table. Featuring the latest in design, comfort and functionality in a manual exam table, it truly offers efficient patient care....
Medicine Products: